REFILE-Newer type 2 diabetes drugs show heart protective quality in study

WASHINGTON, March 19 (Reuters) - A newer class of type 2 diabetes drugs significantly cut the risk of death and hospitalization for heart failure compared with other medicines for the disease, according to data released on Sunday from a so-called real world study sponsored by AstraZeneca.